Coronary heart disease prevalence and its relation to risk factors in American Indians: The strong heart study

American Journal of Epidemiology

Volumn 142, Issue 3, 1995, Pages 254-268

  Howard, Barbara V ^a   Lee, Elisa T ^b   Cowan, Linda D ^b   Fabsitz, Richard R ^c   Howard, Wm James ^a   Oopik, Arvo J ^d,e   Robbins, David C ^a   Savage, Peter J ^c   Yeh, Jeunliang L ^b   Welty, Thomas K ^e  

^a Medlantic Research Institute   (United States)

^b UNIVERSITY OF OKLAHOMA   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^d FITZSIMONS ARMY MEDICAL CENTER   (United States)

^e Aberdeen Area Indian Health Service   (United States)

Author keywords

Coronary disease; Diabetes mellitus; Hypertension; Indians, North American; Insulin; Lipoproteins; Obesity

Indexed keywords

ALBUMIN; FIBRINOGEN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; AMERICAN INDIAN; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY FAT; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; DIABETES MELLITUS; ELECTROCARDIOGRAPHY; FEMALE; HEART INFARCTION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PREVALENCE; PROTEINURIA; RISK FACTOR; SMOKING; UNITED STATES;

AGED; ANTHROPOMETRY; CORONARY DISEASE; DIABETES MELLITUS; EPIDEMIOLOGIC METHODS; FEMALE; HUMAN; HYPERTENSION; INDIANS, NORTH AMERICAN; LIPIDS; LOGISTIC MODELS; MALE; MIDDLE AGE; OBESITY; PREVALENCE; RISK FACTORS; SEX FACTORS; SMOKING; SUPPORT, U.S. GOV'T, P.H.S.; UNITED STATES;

EID: 20244367283     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a117632     Document Type: Article

References (66)

1. Levy RI. Declining mortality in coronary heart disease. Arteriosclerosis 1981;1:312-25.
2. Abbott RD, Garrison RJ, Wilson PW, et al. Coronary heart disease risk: the importance of joint relationships among cholesterol levels in individual lipoprotein classes. Prev Med 1982;11:131-41.
3. Stamler J, Wentworth D, Neaton JD. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356, 222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 1986;256:2823-8.
4. The Pooling Project Research Group. Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: final report of the Pooling Project. J Chronic Dis 1978;31: 201-306.
5. Criqui MH, Heiss G, Cohn R, et al. Plasma triglyceride level and mortality from coronary heart disease. N Engl J Med 1993;328;17:1220-5.
6. Heiss G, Sharrett AR, Barnes R, et al. Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC Study. Am J Epidemiol 1991;134:250-6.
7. The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease. JAMA 1984;251:351-64.
8. Frick MH, Elo O, Haapa K, et al. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. N Engl J Med 1987;317:1237-45.
9. Blankenhom D, Nessim SA, Johnson RL, et al. Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. JAMA 1987;257:3233-40.
10. Sievers ML, Fisher JR. Diseases of North American Indians. In: Rothschild HR, ed. Biocultural aspects of disease. New York, NY: Academic Press, Inc, 1981:191-252.
11. Indian Health Service, US Department of Health and Human Services. IHS chart series book, June 1984. Washington, DC: US GPO, 1984.
12. Office of Technology Assessment, US Congress. Indian health care. Washington, DC: US GPO, 1986. (Publication no. OTA- H-290).
13. Welty TK, Coulehan JL. Cardiovascular disease among American Indians and Alaska natives. Diabetes Care 1993;16(suppl)40.:277-83.
14. Nelson RG, Sievers ML, Knowler WC, et al. Low incidence of fatal coronary heart disease in Pima Indians despite high prevalence of non-insulin-dependent diabetes. Circulation 1990:81:987-95.
15. Sievers ML, Fisher JR. Increasing rate of acute myocardial infarction in Southwestern American Indians. Ariz Med 1979; 36:607-10.
16. Lee ET, Welty TK, Fabsitz R, et al. The Strong Heart Study. A study of cardiovascular disease in American Indians: design and methods. Am J Epidemiol 1990;132:1141-55.
17. Howard BV, Welty TK, Fabsitz RR, et al. Risk factors for coronary heart disease in diabetic and nondiabetic Native Americans: The Strong Heart Study. Diabetes 1992;41(suppl)41.:4-11.
18. Stoddard M, Jarvis B, Blake B, et al. Recruitment of American Indians in epidemiologic research: The Strong Heart Study. Proceedings of the 121st Annual Meeting of the American Public Health Association, San Francisco, California, October 1993.
19. Lipid Research Clinics Program. Manual of laboratory operations. Vol 1. Washington, DC: US Department of Health, Education, and Welfare, 1975. (DHEW publication no. 75-628).
20. Morgan C, Lazarow A. Immunoassay of insulin: two antibody system. Plasma insulin levels in normal, subdiabetic and diabetic rats. Diabetes 1963;12:115-26.
21. von Clauss A. Gerinnungsphysiologische Scnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 1957;17: 237-46.
22. Little RR, England JD, Wiedmeyer HM, et al. Interlaboratory standardization of glycated hemoglobin determinations. Clin Chem 1986;32:358-60.
23. Vasquez B, Flock EV, Savage PJ, et al. Sustained reduction of proteinuria in Type 2 (non-insulin-dependent) diabetes following diet-induced reduction of hyperglycemia. Diabetologia 1984;26:127-33.
24. Chasson AL, Grady HJ, Stanley MA. Determination of creatinine by means of automatic chemical analysis. Tech Bull Regist Med Technol 1960;30:207-12.
25. Prineas RJ, Crow RS, Blackburn H. The Minnesota Code manual of electrocardiographic findings. Littleton, MA: John Wright PSC, 1982.
26. Rose GA, Blackburn H. Cardiovascular survey methods. 2nd ed. Geneva, Switzerland: World Health Organization, 1982. (WHO Monograph Series no. 56G).
27. World Health Organization. WHO Expert Committee on Diabetes Mellitus: second report. Geneva, Switzerland: World Health Organization, 1980. (WHO Technical Report Series no. 646).
28. National Heart, Lung, and Blood Institute. Fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Bethesda, MD: National Heart, Lung, and Blood Institute, 1993. (NIH publication no. 1088).
29. National Center for Health Statistics. Anthropometric reference data and prevalence of overweight, United States, 1976-80. Hyattsville, MD: National Center for Health Statistics, 1987. (Vital and health statistics, series 11, no. 238). (DHHS publication no. (PHS) 87-1688).
30. Bennett PH, Nelson RG, Knowler WC, et al. Urine albumin/creatinine ratio estimates albumin excretion and predicts nephropathy in Type II (non-insulin-dependent) diabetes. (Abstract). Diabetologia 1990;33:A147.
31. Welty TK, Lee ET, Yeh J, et al. Cardiovascular disease risk factors among American Indians: The Strong Heart Study. Am J Epidemiol 1995;142:269-87.
32. The ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol 1989;129:687-702.
33. Sampliner RE, Bennett PH, Comess LJ, et al. Gallbladder disease in Pima Indians: demonstration of high prevalence and early onset by cholecystography. N Engl J Med 1970;283: 1358-64.
34. Ingelfinger JA, Bennett PH, Liebow IM, et al. Coronary heart disease in the Pima Indians: electrocardiographic findings and postmortem evidence of myocardial infarction in a population with a high prevalence of diabetes mellitus. Diabetes 1976; 25:561-5.
35. Liu QZ, Knowler WC, Nelson RG, et al. Insulin treatment, endogenous insulin concentration, and ECG abnormalities in diabetic Pima Indians: cross-sectional and prospective analyses. Diabetes 1992;41:1141-50.
36. Howard BV, Lisse JR, Knowler WC, et al. Diabetes and atherosclerosis in the Pima Indians. Mt Sinai J Med 1982;49: 169-75.
37. Burke GL, Evans GW, Riley WA, et al. Arterial wall thickness is associated with prevalent cardiovascular disease in middle- aged adults: The ARIC Study. Stroke 1995;26:386-91.
38. Simons LA, Friedlander Y, McCallum J, et al. The Dubbo study of the health of elderly: correlates of coronary heart disease at study entry. J Am Geriatr Soc 1991;39:584-90.
39. Furberg CD, Manolio TA, Psaty BM. Major electrocardiographic abnormalities in persons aged 65 and older (the Cardiovascular Health Study). Am J Cardiol 1992;69:1329-35.
40. Rewers M, Shetterly SM, Baxter J, et al. Prevalence of coronary heart disease in subjects with normal and impaired glucose tolerance and non-insulin-dependent diabetes mellitus in a biethnic Colorado population: The San Luis Valley Diabetes Study. Am J Epidemiol 1992;135:1321-30.
41. Mitchell BD, Hazuda HP, Haffner SM, et al. Myocardial infarction in Mexican-Americans and non-Hispanic whites: The San Antonio Heart Study. Circulation 1991;83:45-51.
42. Pan WH, Cedres LB, Liu K, et al. Relationship of clinical diabetes and asymptomatic hyperglycemia to risk of coronary heart disease mortality in men and women. Am J Epidemiol 1986;123:504-16.
43. Barrett-Connor E, Wingard DL. Sex differential in ischemic heart disease mortality in diabetics: a prospective population- based study. Am J Epidemiol 1983;118:489-96.
44. Kännel WB, McGee DL. Diabetes and glucose tolerance as risk factors for cardiovascular disease: The Framingham Study. Diabetes Care 1979;2:120-6.
45. Heyden S, Heiss G, Bartel AF, et al. Sex differences in coronary mortality among diabetics in Evans County, Georgia. J Chronic Dis 1980;33:265-73.
46. Butler WJ, Ostrander LD Jr, Carman WJ, et al. Mortality from coronary heart disease in the Tecumseh Study: long-term effect of diabetes mellitus, glucose tolerance and other risk factors. Am J Epidemiol 1985;121:541-7.
47. Kleinman JC, Donahue RP, Harris MI, et al. Mortality among diabetics in a national sample. Am J Epidemiol 1988;128: 389-401.
48. Gillum RF, Gillum BS, Smith N. Cardiovascular risk factors among urban American Indians: blood pressure, serum lipids, smoking, diabetes, health knowledge and behavior. Am Heart J 1984;107:765-76.
49. Sugarman JR. Prevalence of diagnosed hypertension among diabetic Navajo Indians. Arch Intern Med 1990;150:359-62.
50. Broussard BA, Valway SE, Kaufman S, et al. Clinical hypertension and its interaction with diabetes among American Indians and Alaska Natives: estimated rates from ambulatory care data. Diabetes Care 1993;16:292-6.
51. Helgeson DM, Berg CL, Julh N. Blood pressure comparison in a selected Native American and white population. Public Health Nurs 1993;10:36-41.
52. Howard BV, Davis MP, Pettitt DJ, et al. Plasma and lipoprotein cholesterol and triglyceride concentrations in the Pima Indians: distributions differing from those of Caucasians. Circulation 1983;68:214-22.
53. Gordon T, Castelli WP, Hjortland MC, et al. High density lipoprotein as a protective factor against coronary heart disease: The Framingham Study. Am J Med 1977;62:707-17.
54. Assmann G, Schulte H, Oerwittler W, et al. New aspects in the prediction of coronary artery disease: The Prospective Cardiovascular Munster Study. In: Fidge NH, Nestel PJ, eds. Atherosclerosis VII. Amsterdam, The Netherlands: Elsevier Science Publishers, 1986:19-24.
55. Denke MA, Sempos CT, Grundy SM. Excess body weight: an underrecognized contributor to high blood cholesterol levels in white American men. Arch Intern Med 1993;153: 1093-103.
56. Howard BV. Lipoprotein metabolism in diabetes mellitus. J Lipid Res 1987;28:613-28.
57. Hubert HB, Feinleib M, McNamara PM, et al. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983;67:968-77.
58. Hiller R, Sperduto RD, Podgor MJ, et al. Diabetic retinopathy and cardiovascular disease in type II diabetics: the Framingham Heart Study and the Framingham Eye Study. Am J Epidemol 1988;128:402-9.
59. Jensen I, Borch-Johnsen K, Kofoed-Enevoldsen A, et al. Coronary disease in young type 1 (insulin-dependent) patients with and without nephropathy. Diabetologia 1987;30:144-5.
60. Krolewski AS, Kosinski EJ, Warram JH. Magnitude and determinants of coronary artery disease in juvenile-onset insulin-dependent diabetes mellitus. Am J Cardiol 1987;59:750-5.
61. Robbins DC, Yeh JL, Lee E, et al. High prevalence of proteinuria among American Indians with diabetes or IGT: The Strong Heart Study (SHS). (Abstract). Diabetes 1992;41: 180A.
62. Haffner SM, Stern MP, Gruber MKK, et al. Microalbuminuria: potential marker for increased cardiovascular disease risk factors in nondiabetic subjects. Arterioscler Thromb 1990;10:727-31.
63. Haffner SM, Morales PA, Gruber MK, et al. Cardiovascular risk factors in non-insulin-dependent diabetic subjects with microalbuminuria. Arterioscler Thromb 1993;13:205-10.
64. Howard BV. Insulin, insulin resistance, and dyslipidemia. Ann N Y Acad Sei 1993;683:1-8.
65. Saad MF, Lillioja S, Nyomba BL, et al. Racial differences in the relationship between blood pressure and insulin resistance. N Engl J Med 1992;324:733-9.
66. Lee ET, Howard BV, Savage PJ, et al. Diabetes mellitus and impaired glucose tolerance in three American Indian populations: The Strong Heart Study. Diabetes Care 1995;18: 599-610.